Karcaaltincaba Musturay, Akhan Okan
Department of Radiology, Division of Abdominal and Interventional Radiology, Hacettepe University School of Medicine, Sihhiye, Ankara 06100, Turkey.
Eur J Radiol. 2005 Sep;55(3):340-54. doi: 10.1016/j.ejrad.2005.03.007.
Pelvic lymphocele, also known as lymphocyst, is a cystic structure caused by lymphatic injury usually secondary to pelvic lymphadenectomy and renal transplantation. Lymphoceles can cause morbidity and rarely mortality by compression of adjacent structures and infectious complications. This review discusses etiology and treatment options for pelvic lymphoceles including surgical and percutaneous methods with emphasis on percutaneous techniques particularly in conjunction with sclerotherapy. Percutaneous catheter drainage with sclerotherapy procedure with various sclerosing agents is described in detail. Ethanol, povidone-iodine, tetracycline, doxycycline, bleomycin, talc and fibrin glue can be used as sclerosing agents. Combination of sclerosing agents to percutaneous catheter drainage significantly improves success rate in the treatment of pelvic lymphoceles. Infected lymphoceles are usually treated solely with percutaneous catheter drainage. Percutaneous treatment can be tailored according to volume of lymphoceles. We generally prefer single session sclerotherapy and 1 day catheter drainage in lymphoceles less than 150 mL, and larger ones are treated by multi-session sclerotherapy until daily drainage decreases below 10 mL. Percutaneous treatment preferably with sclerotherapy should be considered as the first-line treatment modality for pelvic lymphoceles due to its effectiveness, widespread applicability on an outpatient basis, ease of procedure and low complication rate.
盆腔淋巴囊肿,也称为淋巴管囊肿,是一种囊性结构,通常继发于盆腔淋巴结清扫术和肾移植后的淋巴损伤。淋巴囊肿可因压迫相邻结构和感染性并发症而导致发病,很少导致死亡。本文综述了盆腔淋巴囊肿的病因及治疗选择,包括手术和经皮治疗方法,重点介绍经皮技术,尤其是与硬化疗法联合使用时。详细描述了使用各种硬化剂进行经皮导管引流加硬化疗法的过程。乙醇、聚维酮碘、四环素、强力霉素、博来霉素、滑石粉和纤维蛋白胶均可用作硬化剂。硬化剂与经皮导管引流联合使用可显著提高盆腔淋巴囊肿的治疗成功率。感染性淋巴囊肿通常仅采用经皮导管引流治疗。经皮治疗可根据淋巴囊肿的体积进行调整。对于小于150 mL的淋巴囊肿,我们一般倾向于单次硬化疗法和1天导管引流,较大的淋巴囊肿则采用多次硬化疗法,直至每日引流量降至10 mL以下。由于经皮治疗(最好联合硬化疗法)具有有效性、门诊广泛适用性、操作简便和并发症发生率低等优点,应被视为盆腔淋巴囊肿的一线治疗方式。